Find a Clinical Trial
Filter
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
Recruiting now
Cancer Center
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Discovery
Glaucoma
All genders
No minimum age
Recruiting now
Department of Ophthalmology
HER2 Negative Breast Cancer
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Home and Bedside Visual Fields
Vision health
All genders
Recruiting now
Department of Ophthalmology
DEcIDED
Dry eyes
All genders
Recruiting now
Department of Ophthalmology
NASA
Dry eyes
All genders
Recruiting now
Department of Ophthalmology
IMPACT/SWAGGER
Non Exudative Age-Related Macular Degeneration Imaged with Swept Source Optical Coherence Tomography
Macular degeneration
All genders
Recruiting now
Department of Ophthalmology
Functional Imaging for Ocular Blood Flow with OCTA
Macular degeneration, Retinal disorders
All genders
Recruiting now
Department of Ophthalmology
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center